SCHEMBL14633435

SCHEMBL14633435

Cc1cc(Nc2ncc3c(=O)n(-c4c(F)cccc4Cl)nc(C)c3n2)ccc1C1CCCN(C)CC1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ WEE1 P30291 13/20 0.55
▸ CYP3A4 P08684 1/20 0.47
▸ KCNH2 Q12809 1/20 0.47
▸ JAK2 O60674 2/20 0.44
▸ EGFR P00533 2/20 0.41
▸ PDGFRB P09619 1/20 0.41
▸ FGFR1 P11362 1/20 0.41
▸ SRC P12931 1/20 0.41
▸ PDGFRA P16234 1/20 0.41
▸ STAT5A P42229 1/20 0.41
▸ ACVR1 Q04771 1/20 0.41
▸ PKMYT1 Q99640 1/20 0.41
▸ TNK2 Q07912 1/20 0.41
▸ PIK3CD O00329 1/20 0.40
▸ CSF1R P07333 1/20 0.40
▸ CDK4 P11802 1/20 0.40
▸ CDK6 Q00534 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14633306 0.96 WEE1 (0.57) WEE1CYP3A4KCNH2JAK2TNK2
SCHEMBL14633018 0.88 WEE1 (0.53) WEE1CYP3A4KCNH2JAK2EGFR
SCHEMBL14633105 0.84 WEE1 (0.52) WEE1CYP3A4KCNH2EGFRTNK2
SCHEMBL14633250 0.82 KCNH2 (0.65) WEE1CYP3A4KCNH2JAK2
SCHEMBL14633158 0.81 WEE1 (0.68) WEE1CYP3A4KCNH2FGFR1SRC
SCHEMBL14633753 0.79 WEE1 (0.49) WEE1CYP3A4KCNH2EGFR
SCHEMBL14633403 0.79 WEE1 (0.54) WEE1CYP3A4KCNH2SRC
SCHEMBL14633164 0.78 WEE1 (0.47) WEE1CYP3A4CSF1RCDK4CDK6
SCHEMBL14633674 0.78 WEE1 (0.66) WEE1
SCHEMBL21876499 0.78 WEE1 (0.57) WEE1CYP3A4KCNH2TNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US claimed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO claimed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US claimed
US-9051327-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2015-06-09 — — US disclosed
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBVIE INC (US) 2014-10-02 — — US disclosed
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US disclosed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO disclosed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 WEE1 1/4885CYP3A4 1925/4885KCNH2 1681/4885
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 WEE1 1/4885CYP3A4 1925/4885KCNH2 1681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback